Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascendis Pharma A/S

163.24
-2.8100-1.69%
Pre-market: 163.240.00000.00%05:56 EDT
Volume:242.52K
Turnover:39.68M
Market Cap:9.77B
PE:-24.14
High:165.74
Open:164.72
Low:162.71
Close:166.05
Loading ...
Sep 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 05, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 28, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 16, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 02, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]